Aging is believed to be a first-order risk factor for most neurodegenerative disorders. The neuronal cell loss that occurs with aging has been partly attributed to increased production of nitric oxide and high caspase activity. Melatonin (MLT) might have a role in the regulation of nitric oxide in the brain. We investigated the effects of MLT on the nitrite/nitrate levels and caspase-3 enzyme activity in the frontal cortex, temporal cortex, and hippocampus of young and aged rats. There was no significant difference between the nitrite levels in the frontal cortex and hippocampus of young and aged animals. In the temporal cortex of aged rats, the nitrite level, however, was significantly higher (P < 0.001). In the aged group, MLT significantly decreased these levels in the brain regions. Caspase-3 enzyme activity in the temporal and frontal cortices was significantly higher in aged rats when compared to the control group (P < 0.05). Melatonin did not cause significant changes in caspase-3 activity in any brain region of both young and aged rats. Thus, brain regions demonstrate different caspase-3 enzyme activities and nitrite levels in the aging process. Exogenous MLT administration might delay brain aging (by moderation of death of neurons and glia) via decreasing the nitrite/nitrate level.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
R. A. Floyd and K. Hensley, “Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases,” Neurobiol. Aging, 23, No. 5, 795–807 (2002).
X. H. Deng, G. Bertini, Y. Z. Xu, et al., “Cytokineinduced activation of glial cells in the mouse brain is enhanced at an advanced age,” Neuroscience, 141, No. 2, 645–661 (2006).
I. Rozovsky, C. E. Finch, and T. E. Morgan, “Age-related activation of microglia and astrocytes: in vitro studies show persistent phenotypes of aging, increased proliferation, and resistance to down-regulation,” Neurobiol. Aging, 19, No. 1, 97–103 (1998).
R. E. Mrak and W. S. Griffin, “Glia and their cytokines in progression of neurodegeneration,” Neurobiol. Aging, 26, No. 3, 349–354 (2005).
M. P. Mattson, “Apoptosis in neurodegenerative disorders,” Nat. Rev. Mol. Cell. Biol., 1, No. 2, 120–129 (2000).
M. P. Mattson, “Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders,” Antioxid. Redox Signal., 8, Nos. 11/12, 1997–2006 (2006).
R. M. Friedlander, “Apoptosis and caspases in neurodegenerative diseases,” New Engl. J. Med., 348, No. 14, 1365–1375 (2003).
C. M. Troy and G. S. Salvesen, “Caspases in the brain,” J. Neurosci. Res., 69, No. 2, 145–150 (2002).
S. M. McCann, “The nitric oxide hypothesis of brain aging,” Exp. Gerontol., 32, Nos. 4/5, 431–440 (1997).
A. Navarro and A. Boveris, “Mitochondrial nitric oxide synthase, mitochondrial brain dysfunction in aging, and mitochondria-targeted antioxidants,” Adv. Drug. Deliv. Rev., 60, 1534–1544 (2008).
P. K. Kim, Y. G. Kwon, H. T. Chung, and Y. M. Kim, “Regulation of caspases by nitric oxide,” Ann. New York Acad. Sci., 962, 42–52 (2002).
J. Sastre, F. V. Pallardó, and J. Viña, “Mitochondrial oxidative stress plays a key role in aging and apoptosis,” IUBMB Life, 49, No. 5, 427–435 (2000).
M. E. Götz, E. Ahlbom, B. Zhivotovsky, et al., “Radical scavenging compound J 811 inhibits hydrogen peroxideinduced death of cerebellar granule cells,” J. Neurosci. Res., 56, No. 4, 420–426 (1999).
A. M. Stranahan and M. P. Mattson, “Recruiting adaptive cellular stress responses for successful brain ageing,” Nat. Rev. Neurosci., 13, No. 3, 209–216 (2012).
M. Tajes Orduña, C. Pelegrí Gabalda, J. Vilaplana Hortensi, et al., “An evaluation of the neuroprotective effects of melatonin in an in vitro experimental model of age-induced neuronal apoptosis,” J. Pineal Res., 46, No. 3, 262–267 (2009).
Y. Hong, K. J. Palaksha, K. Park, et al., “Melatonin plus exercise-based neurorehabilitative therapy for spinal cord injury,” J. Pineal Res., 49, No. 3, 201–209 (2010).
A. Leja-Szpak, J. Jaworek, P. Pierzchalski, and R. J. Reiter, “Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1),” J. Pineal Res., 49, No. 3, 248–255 (2010).
R. Hardeland, D. X. Tan, and R. J. Reiter, “Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines,” J. Pineal Res., 47, No. 2, 109–126 (2009).
K. G. Akbulut, B. Gonul, and H. Akbulut, “Exogenous melatonin decreases age-induced lipid peroxidation in the brain,” Brain Res., 1238, 31–35 (2008).
A. R. Meki, D. Esmail Eel, A. A. Hussein, and H. M. Hassanein, “Caspase-3 and heat shock protein-70 in rat liver treated with aflatoxin B1: effect of melatonin,” Toxicon, 43, No. 1, 93–100 (2004).
L. Casciola-Rosen, D. W. Nicholson, T. Chong, et al., “Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death,” J. Exp. Med., 183, No. 5, 1957–1964 (1996).
K. M. Miranda, M. G. Espey, and D. A. Wink, “A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite,” Nitric Oxide, 5, No. 1, 62–71 (2001).
A. M. Lynch and M. A. Lynch, “The age-related increase in IL-1 type I receptor in rat hippocampus is coupled with an increase in caspase-3 activation,” Eur. J. Neurosci., 15, No. 11, 1779–1788 (2002).
M. K. Lucin and T. Wyss-Coray, “Immune activation in brain aging and neurodegeneration: too much or too little?” Neuron, 64, No. 1, 110–122 (2009).
G. E. Landreth, “Microglia in central nervous system diseases,” J. Neuroimmune Pharmacol., 4, No. 4, 369–370 (2009).
J. P. Godbout and R. W. Johnson, “Age and neuroinflammation: a lifetime of psychoneuroimmune consequences,” Immunol. Allergy Clin. North Am., 29, No. 2, 321–337 (2009).
E. Siles, E. Martínez-Lara, A. Cañuelo, et al., “Agerelated changes of the nitric oxide system in the rat brain,” Brain Res., 956, No. 2, 385–392 (2002).
A. Law, S. Doré, S. Blackshaw, et al., “Alteration of expression levels of neuronal nitric oxide synthase and haem oxygenase-2 messenger RNA in the hippocampi and cortices of young adult and aged cognitively unimpaired and impaired Long-Evans rats,” Neuroscience, 100, No. 4, 769–775 (2000).
D. Vernet, J. J. Bonavera, R. S. Swerdloff, et al., “Spontaneous expression of inducible nitric oxide synthase in the hypothalamus and other brain regions of aging rats,” Endocrinology, 139, No. 7, 3254–3261 (1998).
P. Liu, Y. Jing, and H. Zhang, “Age-related changes in arginine and its metabolites in memory-associated brain structures,” Neuroscience, 164, No. 2, 611–628 (2009).
S. Blanco, F. J. Molina, L. Castro, et al., “Study of the nitric oxide system in the rat cerebellum during aging,” BMC Neurosci., 11, 78 (2010).
C. Hutton, B. Draganski, J. Ashburner, and N. Weiskopf, “A comparison between voxel-based cortical thickness and voxel-based morphometry in normal aging,” Neuroimage, 48, No. 2, 371–380 (2009).
A. Schuitemaker, T. F. van der Doef, R. Boellaard, et al., “Microglial activation in healthy aging,” Neurobiol. Aging, 33, No. 6, 1067–1072 (2012).
X. G. Luo, J. Q. Ding, and S. D. Chen, “Microglia in the aging brain: relevance to neurodegeneration,” Mol. Neurodegener., 5, 12 (2010).
A. Das, A. Belagodu, R. J. Reiter, et al., “Cytoprotective effects of melatonin on C6 astroglial cells exposed to glutamate excitotoxicity and oxidative stress,” J. Pineal Res., 45, No. 2, 117–124 (2008).
K. G. Akbulut, H. Akbulut, N. Akgun, and B. Gonul, “Melatonin decreases apoptosis in gastric mucosa during aging,” Aging Clin. Exp. Res., 24, No. 1, 15–20 (2012).
Y. Zhang, E. Chong, and B. Herman, “Age-associated increases in the activity of multiple caspases in Fisher 344 rat organs,” Exp. Gerontol., 37, No. 6, 777–789 (2002).
A. Zhang, D. E. Lorke, S. X. Wu, and D.T. Yew, “Caspase-3 immunoreactivity in different cortical areas of young and aging macaque (Macaca mulatta) monkeys,” Neurosignals, 15, No. 2, 64–73 (2007).
J. Chetsawang, P. Govitrapong, and B. Chetsawang, “Melatonin inhibits MPP+-induced caspase-mediated death pathway and DNA fragmentation factor-45 cleavage in SK-N-SH cultured cells,” J. Pineal Res., 43, No. 2, 115–120 (2007).
About this article
Cite this article
Akbulut, K.G., Guney, S., Cetin, F. et al. Melatonin Delays Brain Aging by Decreasing the Nitric Oxide Level. Neurophysiology 45, 187–192 (2013). https://doi.org/10.1007/s11062-013-9368-3
- nitric oxide
- temporal cortex
- frontal cortex